Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 05.12.2024
JPMorgan ETFs (Ireland) ICAV
COMPANY ANNOUNCEMENT
For Immediate Release
05 December 2024
JPMorgan ETFs (Ireland) ICAV
RE: Dividends
The Directors of JPMorgan ETFs (Ireland) ICAV (the “Company”) wish to announce the following dividends which are ex dividend as of the 12 December 2024, record date as of the 13 De [ … ]
Thu, 05.12.2024
KWS SAAT SE & Co. KGaA
KWS Annual Shareholders’ Meeting approves dividend of €1.00 and elects Dr. Hagen Duenbostel to the Supervisory Board
At today's Annual Shareholders’ Meeting, the shareholders of KWS SAAT SE & Co. KGaA (ISIN: DE0007074007) approved the management's proposed resolutions on all items on the agenda with a clear majority. The dividend payout for fi [ … ]
Thu, 05.12.2024
Marinomed Biotech AG
Korneuburg, Austria, December 5, 2024 - Marinomed Biotech AG (the “Company”) announces that the Management Board has resolved today to increase the Company's share capital again by EUR 83,750 to EUR 1,778,333 by issuing 83,750 new no-par value bearer shares against cash contributions (the “Second Capital Increase”). The new shares will be issued fr [ … ]
Thu, 05.12.2024
ZenaTech Inc.
TORONTO
ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone solutions and enterprise SaaS (Software-as-a-Service) solutions, announces today that it has signed an LOI (Letter of Intent) to acquire its first land survey company, part of a larger roll-up strategy to disrup [ … ]
Thu, 05.12.2024
BioLizard nv
BioLizard Launches Bio|Verse® Navigator for Easy Exploration of Complex Biomedical Data
Bio|Verse Navigator can accelerate data exploration and interpretation workflows multifold, reducing time-to-insight for researchers.
The application combines advanced BioLizard’s bioinformatics expertise in handling various customer datasets with powerful vi [ … ]
Thu, 05.12.2024
Edison Investment Research Limited
London, UK, 5 December 2024
Edison issues report on SDCL Energy Efficiency Income Trust (SEIT)
Edison issues report on SDCL Energy Efficiency Income Trust (LSE: SEIT).
SDCL Energy Efficiency Income Trust (SEEIT) reported robust H125 results. Its net asset value (NAV) increased marginally to 90.6p (90.5p at 31 March 2024), demonstrating res [ … ]
Thu, 05.12.2024
Galimedix, Inc.
Galimedix Therapeutics initiates Phase 1 study with oral small molecule, GAL-101, an amyloid beta (Aβ) aggregation modulator
Study to evaluate safety, tolerability and pharmacokinetics of single and multiple ascending oral doses of GAL-101 in healthy volunteers
Planned indications include Alzheimer’s disease, dry AMD and glaucoma
Phase 2 study [ … ]
Thu, 05.12.2024
TRT
EQS-Media / 05.12.2024 / 12:58 CET/CEST
Recep Tayyip Erdoğan, President of the Republic of Turkey; Mehmet Zahid Sobacı, Director General of TRT
İstanbul — Influential leaders, intellectuals, and experts from around the world convened in Istanbul for TRT World Forum 2024. Held for the 8th time this year under the theme “A World at Breaking [ … ]
Thu, 05.12.2024
Formycon AG
Press Release // December 5, 2024
Formycon joins the SDAX of the German Stock Exchange
Formycon shares will be part of the DAX index family, ranking among the 70 largest German companies below the MDAX
Enhanced share attractiveness following recent uplisting to the Prime Standard
Formycon shares to be included in the index effective as of Decem [ … ]
Thu, 05.12.2024
Viromed Medical AG
Viromed Medical AG: Cooperation between relyon plasma GmbH and Viromed Medical GmbH
Pinneberg/Regensburg, 5 December 2024 –Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) is pleased to inform about the cooperation between its subsidiary Viromed Medical GmbH and relyon plasma GmbH, a subsidiary of TDK Electronics AG (link to the original news [ … ]